Novavax's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; Novavax is scheduled to report earnings on May 7, 2024, and the estimated EPS forecast is €-0.88. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 186.99M	$ 424.43M	$ 80.95M	$ 357.40M	$ 628.30M
Gross Profit	$ 186.99M	$ 424.43M	$ 46.87M	$ 175.63M	$ 193.71M
EBIT	$ -126.42M	$ 63.18M	$ -291.61M	$ -179.91M	$ -161.97M
EBITDA	$ -115.10M	$ 73.25M	$ -282.57M	$ -172.69M	$ -153.63M
Net Income Common Stockholders	$ -130.78M	$ 58.01M	$ -293.90M	$ -182.25M	$ -168.61M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 651.10M	$ 516.27M	$ 635.28M	$ 1.35B	$ 1.28B
Total Assets	$ 1.66B	$ 1.69B	$ 1.54B	$ 2.26B	$ 2.27B
Total Debt	$ 222.11M	$ 198.94M	$ 199.06M	$ 549.78M	$ 438.09M
Net Debt	$ -428.99M	$ -317.33M	$ -436.23M	$ -797.40M	$ -842.49M
Total Liabilities	$ 2.34B	$ 2.44B	$ 2.44B	$ 2.89B	$ 2.83B
Stockholders Equity	$ -678.35M	$ -754.52M	$ -895.58M	$ -634.08M	$ -565.99M
Cash Flow	-
Free Cash Flow	$ -57.86M	$ -178.89M	$ -345.39M	$ -140.80M	$ -68.23M
Operating Cash Flow	$ -39.70M	$ -171.92M	$ -325.59M	$ -117.78M	$ -38.71M
Investing Cash Flow	$ -18.39M	$ -7.78M	$ -23.56M	$ -22.06M	$ -29.52M
Financing Cash Flow	$ 197.12M	$ 61.34M	$ -354.38M	$ 191.44M	$ -30.98M

Currency in USD

Novavax Earnings and Revenue History

Income Statement >

Novavax Debt to Assets

Balance Sheet >

Novavax Cash Flow

Cash Flow >

Novavax Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing